Leptin is one of the main adipokines secreted in breast tissue, and has been associated with epithelial-mesenchymal transition (EMT) and tumor progression in breast cancer. Leptin promotes EMT, cell migration and invasion in epithelial breast cells, leading to tumor progression. However, the molecular mechanism that underlies these events is not fully understood; however, the activation of different signaling pathways appears to be essential. In this sense, the effect of leptin on the activation of kinases like Src and FAK, which regulate signaling pathways that activate the EMT program, has not been completely described. Therefore, we investigated the involvement of these kinases using an in vitro model for leptin-induced EMT process in the non-tumorigenic MCF10A cell line. To this end, MCF10A cells were stimulated with leptin, and Src and FAK activation was assessed. Specific events occurring during EMT were also evaluated in the presence or absence of the kinases's chemical inhibitors PP2 and PF-573228. For instance, we tested the expression and subcellular localization of the EMT--catenin, by western blot and immunofluorescence. We also evaluated the secretion and activation of matrix metalloproteases (MMP-2 and MMP-9) by gelatin zymography. Invasiveness properties of leptin-stimulated cells were determined by invadopodia formation assays, and by the transwell chamber method. Our results showed that leptin promotes EMT through Src and FAK activation, which leads to the secretion and activation of MMP-2 and MMP-9, invadopodia formation and cell invasion in MCF10A cells. In conclusion, our data suggest that -catenin, the secretion of MMP-2, MMP-9, the invadopodia formation and invasion in MCF10A cells in a Src and FAK-dependent manner.
Introduction
Leptin is a 16 kDa hormone secreted mainly by adipose tissue, and in lesser extent by the placenta, stomach, fibroblasts, skeletal muscle, normal and tumorigenic mammary epithelial tissue [1] . Leptin plays an important role in the regulation of energy homeostasis, endocrine and immune functions, as well as in lipid and glycolytic metabolism [2, 3] . The overexpression of leptin and its receptor, the ObR, has been associated to tumor progressionrelated events in breast cancer [4] [5] [6] . Leptin exerts its effects through binding with the ObR receptor, promoting the activation of several signaling pathways such as MAPK, PI3K/AKT and JAK/STAT [3, 7, 8] . The signaling pathways activated by leptin regulate cell proliferation, migration, invasion and epithelial-mesenchymal transition (EMT) [4, 5, [9] [10] [11] .
The EMT is a reversible cellular trans-differentiation program from epithelial to a mesenchymal phenotype, which provides greater plasticity and dynamism to the cells [3, [12] [13] [14] . EMT is a physiological process necessary for embryonic development, wound healing and tissue regeneration; however, it is also associated with cancer progression [12, 13] . At molecular level, EMT is characterized by the loss of epithelial markers such as E-cadherin, ZO-1, claudins, and acquisition of mesenchymal markers including N-cadherin, vimentin, Hic-5 and matrix metalloproteases (MMPs) [3, 15] . To initiate the EMT program, signals are required that activate specific transcription factors (TFs) such as Snail, Slug, Zeb and Twist [13] . These TFs directly regulates genes involved in cell adhesion, polarity and cytoskeleton reorganization [16] . Overexpression of these TFs in epithelial cells induces either partial or complete changes from an epithelial to mesenchymal morphology, associated with increased motility, invasive capacity and resistance to chemotherapy [17] [18] [19] . In normal conditions, the epithelial cells maintains adherent junctions, where E-cadherin forms a complex with βcatenin in the cell membrane [3, 20] . During the EMT β-catenin translocates from the membrane to the nucleus where it establishes a complex with the TFs TCF/LEF. This complex induce the expression of EMT-related genes, by recognizing the consensus sequence T/A-CAAAG found in the HMG box in the promoter region of genes such as MYC, CCND1, SNAI1 and TWIST1 [21] [22] [23] . Among these, Twist is a 28 kDa, basic helix-loophelix (bHLH) domain-containing TF, with a fundamental role in cell invasion and cancer progression [24] . The known mechanism by which Twist favors cell migration and invasive capabilities of the cells is through the binding to the consensus sequence CANNTG of the CDH1 promoter to repress the expression of E-cadherin, leading to the loss of intercellular adhesions [25] . Twist is also necessary for the invadopodia formation [26] .
Cell invasion is a process associated to EMT, which requires the degradation of the extracellular matrix (ECM) by the tumor cell to allow its infiltration to the adjacent tissue [27] . To achieve this, one of the primary structures formed during the local invasion is the invadopodia, which are membrane protrusions rich in actin puncta [28, 29] . The invadopodia formation is required for the local degradation of ECM components through the secretion and activation of MMP-2 and MMP-9, and MMP-14 [28] [29] [30] . MMP-2 and MMP-9 (also called gelatinase A and B, respectively) have been correlated with the invasive stage of carcinomas due to their ability to degrade gelatin and collagen type IV, the main components in the basal membrane [29, 31] . Experimental evidence suggests that MMP-2 and MMP-9 also contribute to the initiation and progression of breast cancer by cleaving and activating diverse proteins involved in angiogenesis, invasion and metastasis [32] . In addition, a high activity of MMP-2 and MMP-9 has been observed in serum and tissue of patients with breast cancer compared to healthy patients [33, 34] . Several signaling pathways, such as WNT, PI3K/AKT, MAPK, JNK, focal adhesion kinase (FAK) and Src, are activated during the remodeling of the ECM [35] . Among these kinases, the secretion and activation of MMP-2 and MMP-9 in breast cancer cell lines was shown to be dependent on cytosolic tyrosine kinases Src [36] [37] [38] [39] , and FAK [40, 41] . Both enzymes are necessary for proliferation, cell migration, invasion, and metastasis, at least in part for their participation in the regulation of the expression and activation of MMPs [38, [40] [41] [42] .
Previous reports using the non-tumorigenic breast epithelial cell line MCF10A demonstrated that leptin induces a partial EMT, where the cells change from an epithelial to a mesenchymal morphology [43] . This phenotype was characterized by a leptin-induced activation of FAK and ERK, which correlated with an increase in the expression of the intermediate filament vimentin, as well as the relocation of E-cadherin from membrane to cytoplasm [43] . These events favored the collective cell migration of MCF10A cells [43] . However, the mechanisms by which leptin activate diverse signaling pathways, and how the kinases contribute to EMT are not fully understood. Therefore, the aim of this research was to determine the role of Src and FAK in expression of EMT-related transcription factors and invasion in MCF10A cells stimulated with leptin. We found that leptin activates Src and FAK, leading to a variety of EMT-associated events, such as expression of EMT-related the TFs, Twist an -catenin, as well as MMPs secretion, invadopodia formation and invasion in the non-tumorigenic MCF10A epithelial cell line. This report provides insights on the signaling pathways operating downstream of the leptin-induced EMT, and their ultimate functional effectors which contributes to this process.
Materials and Methods

Materials
Recombinant human leptin, FAK (PF-573228) and Src (PP2) inhibitors were obtained from Sigma-Aldrich (St Louis, MO, USA). Mouse anti-actin, rabbit anti-FAK and rabbit? anti-Src antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Rabbit anti-GAPDH antibody was from Cell Signaling (Danvers, MA, USA). The phospho-specific antibody against FAK, rabbit anti-pY397, was obtained from Invitrogen (Carlsbad, CA, USA). The phospho-specific antibody against Src, rabbit anti-pY418, was obtained from MyBiosource (San Diego, CA, USA). The secondary HRP-conjugated antibodies were from Millipore (Billerica, MA, USA), and the anti-mouse and anti-rabbit conjugated with Alexa Fluor 488 antibodies were from Invitrogen (Carlsbad, CA, USA). TRITC conjugated phalloidin was purchased from Cytoskeleton (Denver, CO, USA).
Cell culture
The non-tumorigenic mammary epithelial cell line MCF10A (ATCC, VA, USA) was cultured in DMEM/F12 media (50:50, V:V; Sigma-Aldrich, St Louis, MO) supplemented with 5% fetal bovine serum (FBS) and 1% antibiotics (penicillin G/Streptomycin, Gibco, Waltham, MA) in a humidified atmosphere containing 5% CO2 at 37 ºC. For experimental purposes, cell cultures were serum-starved for 4 h before treatment with either FAK or Src inhibitors and/or leptin. Cell cultures were used between passages 3-15.
Cell stimulation
MCF10A cell cultures were washed with PBS, and then treated with FAK (10 µM) or Src (10 µM) inhibitors and/or leptin for the times and concentrations indicated in the figure legends. Cell cultures were grown to confluence in 60 mm plates containing 3 mL of DMEM/F12 for each experimental condition. Cell stimulation was terminated by removing the medium, and solubilizing the cells in 0.5 mL of ice-cold radioimmune precipitation assay (RIPA) buffer, containing 50 mM HEPES pH 7.4, 150 mM NaCl, 1 mM EGTA, 1 mM sodium orthovanadate, 100 mM NaF, 10 mM sodium pyrophosphate, 10% glycerol, 1% Triton X-100, 1% sodium deoxycholate, 1.5 mM MgCl2, 0.1% SDS and 1 mM phenylmethylsulfonyl fluoride (PMSF).
Western blot
Whole cell lysates (20 µg) were resolved on 10% SDS-polyacrylamide gels and transferred to nitrocellulose membranes. To block non-specific binding the membranes were incubated in 5% (w/v) non-fat dried milk in TBS/T (0.05% tween 20 in TBS) for 2 h at room temperature (RT). Membranes were then incubated with the primary antibodies, anti-Twist, anti-β-catenin, anti-actin, anti-pY397, anti-FAK, anti-pY418 and anti-Src overnight at 4 °C (1:1000 dilution). Next, the membranes were washed with TBS/T and incubate with HRP-conjugated antibodies (1:5000 dilution) for 2 h, at RT. Membranes were developed using an enhanced chemiluminescence detection system from Bio-Rad (Hercules, CA, USA).
Immunofluorescence and F-actin staining
MCF10A cells were seeded on glass coverslips, grown to 70% confluence, and stimulated either with or without leptin for 24 and 48 h. Cells were fixed for 5 min with 4% paraformaldehyde in PBS and permeabilized with 0.2% Triton-X100 in PBS at RT. For immunofluorescence (IF) assays, non-specific staining was blocked with 3% bovine serum albumin in PBS for 1 h at RT. Then, the cells were incubated 2 h at RT with the anti-Twist, anti-β-catenin antibodies (1:250 dilution), followed by a 2 h incubation at RT with an antirabbit conjugated to Alexa Fluor 488 secondary antibody (1:400 dilution). For F-actin staining, cells were incubated with TRITC-conjugated phalloidin (1:1000 dilution) for 30 min at RT. Nucleus were counterstained with 4´6-diamidino-2-phenylindole and samples were mounted with Fluoroshield/DAPI media (Sigma-Aldrich, St Louis, MO, USA), and imaged with an Olympus BX43 microscope, using the 100X immersion objective. Images were analyzed with ImageJ software [44] .
Gelatin zymograms
To assess MMP-2 and MMP-9 activity, MCF10A cells were stimulated with leptin and/or kinases inhibitors for the time and concentrations indicated in the figure legends. The conditioned medium was collected and concentrated using 30 kDa cutoff ultra-centrifugal filter units (Amicon, Merck-Millipore, MA). Protein concentration was determined by Bradford method [45] , and 20 µg of concentrated supernatant of each condition were assayed for proteolytic activity on gelatin-substrate gels [46] . Briefly, samples were mixed with nonreducing buffer containing 2.5% SDS, 1% sucrose and 4 mg/mL phenol red, and separated in 8% acrylamide gels co-polymerized with 1 mg/mL gelatin, as previously described [20] . After electrophoresis at 72 V for 2.5 h, the gels were rinsed twice in 2.5% Triton X-100, and then incubated in 50 mM Tris-HCl pH 7.4 and 5 mM CaCl2 assay buffer at 37 °C for 24 h. Gels were fixed and stained with 0.25% Coomassie Brilliant Blue G-250 in 10% acetic acid and 30% methanol. Proteolytic activity was detected as clear bands against the background stain of undigested substrate in the gel. Quantification was performed using ImageJ software [44] .
Invadopodia formation assays
MCF10A cells were treated with leptin 400 ng/mL and then seeded in coverslips that were previously treated for invadopodia formation assays, as described [47] . Briefly, the coverslips were incubated with 20% sulfuric acid overnight and sterilized with 96% ethanol. Then, the coverslips were covered with 50 μg/mL of poly-L-Lysine diluted in PBS, followed by a treatment with 0.5% glutaraldehyde in PBS, and a final incubation with 0.2% gelatin solution in PBS at 37 °C for 30 min. Pre-treated MCF10A cells were cultured for 6 h in serum supplemented medium. The cells on the coverslips were fixed and permeabilized with 4% formaldehyde/0.5% Triton X-100 in PBS, blocked with 3% BSA and incubated with phalloidin-TRITC for 30 min at 37 °C, coverslips were mounted using Fluoroshield/DAPI media and finally visualized in a Olympus BX43 microscope, using the 100X immersion objective. Images were analyzed with Image J software.
Cell Invasion assays
Matrigel invasion assays were performed following the transwell chamber method [48] , using 24 well plates containing inserts of 8 m pore size (Corning Inc, Kennebunk, ME). Briefly, 30 µL of Matrigel (Corning) was added into the inserts and kept at 37 °C for 30 min to form a semisolid matrix. Untreated or treated cells with FAK or Src inhibitors were plated at 1x10 5 cells per insert in serum-free medium on the top chamber. The lower chamber of the transwell contained 600 µl DMEM supplemented or not with leptin 400 ng/mL. Cells were incubated for 48 h at 37 °C in a 5% CO2 atmosphere. Following incubation, cells and Matrigel on the upper surface of the transwell membrane were gently removed with cotton swabs. Invading cells on the lower surface of the membrane were washed and fixed with methanol for 5 min, and stained with 0.1% crystal violet diluted in PBS. Cell quantification was performed using a hemocytometer, and an Olympus BX43 microscope with the 100X objective.
Statistical analysis
Results are expressed as the mean ± SD. Data was statistically analyzed using one-way ANOVA and the comparisons were performed using Newman-Keuls and Dunette multiple comparison tests. Statistical probability of p <0.05 was considered significant.
Results
Leptin induces FAK and Src activation in MCF10A non-tumorigenic epithelial breast cells
Kinase activation is a fundamental process for cancer progression and metastasis [49, 50] . Src and FAK activation is triggered by the autophosphorylation at Y418 and Y397, respectively [49, 51, 52] . Emerging evidence from our lab and others showed that these kinases may also contribute to early events during EMT [53] [54] [55] [56] . Furthermore, we reported previously that leptin induces the activation of FAK, and in consequence a partial EMT was detected in MCF10A cells [43] . In this work we further explored whether leptin induces the activation of FAK and Src in MCF10A cells, and how these kinases were associated to the expression of the downstream EMT-related TFs, Twist -catenin. Therefore, we initiated our studies by analyzing the activation of Src and FAK, as both kinases are associated to the induction of Twist and -catenin [57, 58] . To this end, MCF10A cultures were stimulated with leptin 400 ng/mL and protein extracts were obtained at different time points for Western blot analyses of Src and FAK activation. Figure 1 shows that leptin induces Src phosphorylation in Y418 between 15-30 min of stimulation ( Fig. 1A, C) , while FAK Y397 phosphorylation occurs within 10-15 min (Fig. 1B, D) , consistent with our previous report [43] . These data suggest that FAK and Src, two kinases involved in cell proliferation and migration are activated by leptin. 
Leptin regulates the expression and subcellular localization of Twist and β-catenin in MCF10A epithelial breast cells
Twist and -catenin are TFs that play an important role during EMT, tumor progression, chemoresistance, and cancer stem cell (CSC) maintenance [59] [60] [61] . Importantly, leptin induces the expression of Twist and β-catenin in breast cancer cells [9, 10] . Therefore, we evaluated whether leptin induces the expression of these two TFs in a cellular model of nontumor mammary epithelium. To determine the expression and subcellular localization of Twist and -catenin in MCF10A cells stimulated with leptin, Western blot and immunofluorescence analyses were performed. An early maximum peak of Twist expression was detected after 3 h of leptin treatment, which gradually decreased at 12 h and was lost after 48 h of the stimulus ( Fig. 2A ). Quantification and statistical analyses of the Western blots ( Fig. 2B ), as well as epifluorescence microscopy imaging (Fig. 2D ) confirmed these results, and demonstrated that Twist is largely located in the nucleus at all times tested. Conversely, β-catenin expression in MCF10A cells stimulated with leptin remained stable during the first 24 h of treatment ( Fig. 2A, C) . β-catenin was induced after 48 h of leptin stimulus, as corroborated by statistical analyses. IF analyses showed that β-catenin is located at the cell membrane in unstimulated cells. Interestingly, within 3 h of treatment, β-catenin is predominantly located in the nucleus. After 6 h of leptin treatment β-catenin seems to acquire an equilibrium state between the cell membrane and the nucleus, being predominantly located at the membrane; this equilibrium is lost after 48 h when β-catenin returns to the nucleus (Fig. 2E ). This data strongly suggest that leptin induce an early activation and nuclear translocation of Twist and β-catenin, and may act as TF of EMTassociated events. 
Leptin regulates the expression and subcellular localization of Twist and β-catenin in a Src and FAK-dependent manner in MCF10A cells
Twist and β-catenin are downstream effectors of different kinases and signaling pathways [24] . We focused on the effect of Src and FAK in the activation of these TFs, as both kinases are associated to EMT-related events [15, 43, 51] . To address this, we took advantage of the specific Src and FAK inhibitors, PP2 or PF-573228, respectively. MCF10A cells were pre-treated with either inhibitor, and then stimulated with leptin for 24 and 48 h. Western blot and IF analyses showed that in the presence of the Src inhibitor (PP2) the leptindependent increase observed for the two TFs, Twist and β-catenin, was abolished ( Fig. 3A -C, G). These data suggest that leptin may exert its effect in the activation of these TFs, at least partially, via Src signaling pathway. On the other hand, the inhibitor for FAK (PF-572238) only had an inhibitory effect on the leptin-induced expression of Twist, as this TF was expressed at similar levels observed in non-treated control cells (Fig. 3D, E, H) . No changes in the levels of expression of β-catenin induced by leptin were observed upon FAK inhibition (Fig. 3D, F) . Moreover, the leptin-induced nuclear distribution of β-catenin was maintained in the presence of the FAK inhibitor (Fig. 3H) . These data suggest that FAK signaling may be involved in the expression and transcriptional activation of Twist, but not in the β-catenin pathway. Representative images of epifluorescence microscopy using 40X magnification. MCF10A cells were pre-treated with PP2 and PF-573228 and subsequently stimulated with leptin (400 ng/mL). The subcellular localization of G) Twist and H) β-catenin is shown in green, and in blue the DNA was counterstained with DAPI.
Leptin induces MMP-2 and MMP-9 secretion in a Src-and FAK-dependent fashion in MCF10A cells
MMPs are a family of endopeptidases capable to degrade the ECM components, thus they are fundamental players for tumor progression, by promoting invasion through the basement membrane and interstitial matrix, angiogenesis, and growth of tumor cells [62, 63] . MMP-2 and MMP-9 expression is elevated in malignant tumors and largely contribute to the ability of tumor cells to metastasize, as they efficiently degrade collagen type IV, which is the main component of the basement membrane [64] . To date, little information is available about the regulation of MMP-2 and MMP-9 expression and secretion during EMT [65] , and less is our knowledge on how leptin mediates this process. Therefore, to determine whether leptin induces the MMP-2 and MMP-9 secretion and activation, gelatin zymograms were performed. The MCF10A cells were treated with increasing concentrations of leptin for 24 h (Fig. 4A) , the supernatant was collected, concentrated and 20 µg of protein were used to assay activity of both MMPs. Densitometric and statistical analyses, demonstrated that 400 ng/mL of leptin induced the highest level of activation of both MMPs (Fig. 4B, C) . Therefore, we chose this concentration for further experimentation, and treated the cells for different times (Fig. 4D-F ). In this instance, we detected that activity of both MMPs further increased after 6 h of leptin treatment (Fig. 4D ). It is noteworthy that MMP-2 activation was greater than MMP-9. Then, to establish whether the Src and FAK regulate the secretion of MMP-2 and MMP-9, the inhibitors PP2 and PF-573228 were used. Zymograms showed that inhibition of both kinases impaired the leptin-induced activation of MMP-2 and MMP-9; densitometric analyses of three independent biological replicates confirmed that the inhibitory effect was statistically significant (Fig. G-L) . These data suggest that the leptininduced activation of MMP-2 and MMP-9 relies in the Src and FAK signaling pathways. 
Leptin induce the formation of stress fibers in a Src-and FAK-dependent manner in MCF10A cells
Stress fibers are essential for cell motility and maintenance of structure [66] . The remodeling of actin filaments during EMT is essential necessary [67] . Our group and others have shown that during leptin-induced EMT of MCF10A cells [43] , and in several cancer cell lines [51, 68, 69] , this hormone promotes the formation of stress fibers [70, 71] . However, understanding of how this process is regulated is still limited. We then asked whether the leptin-induced activation of the kinases Src and FAK had an effect in the formation of stress fibers in MCF10A cells. First, we verified that leptin indeed promoted the formation of stress fibers, as expected the leptin treated cells treated with leptin 400 ng/mL more and thicker actin filaments with a linear distribution, compared to the less and circular fibers observed in non-treated control cells (Fig. 5A, B [43] . This leptin induced-effect was abolished in MCF10A cells that were pre-treated with the Src (PP2, Fig. 5A ), but not with the FAK (PF-573228) inhibitor (Fig. 5B) . We showed previously that leptin treatment induces a morphological change from a cuboid epithelial morphology to an enlarged mesenchymal phenotype in MCF10A cells [43] . We observed that treatment with inhibitors for both kinases prevented the morphological changes observed with leptin alone (Fig. 5) . These data suggests that cytoskeleton modifications during EMT may rely in the activation of these two kinases.
Leptin induces invadopodia formation in a FAK and Src-dependent pathway in MCF10A cells
Invasive properties of the cells correlate with a dynamic membrane structure rich in actin [72] . These structures are membrane protrusions called invadopodia, and function as matrix adhesion sites [73] , possess the ability to degrade the ECM components, and are characteristic of invasive tumor cells [74] . An actin-core is formed during initial steps of invadopodia assembly, which acquires a perpendicular distribution to the ECM and the membrane and can be frequently observed as actin puncta [75] . Considering the effect that leptin excreted in the actin cytoskeleton ( Fig. 5) , we sought to determine whether leptin is also capable to induce the invadopodia formation in MCF10A cells. Therefore we performed in vitro invadopodia formation assays, using Alexa Fluor 488-labeled gelatin assays, which allow to detect both, the presence of invadopodia and their activity using fluorescence microscopy [76] . Our results show that control cells do not present actin puncta, and are unable to degrade the gelatin matrix (Fig. 5C ). However, upon leptin treatment, the cells presented actin puncta formation which colocalized with areas of gelatin degradation (observed as black dots, indicated by white arrows; Fig. 5C ). (B) for 30 min and subsequently with leptin (400 ng/mL) for 24 h. Actin filaments were detected with Phalloidin-TRITC (red) and DNA was counterstained with DAPI. Images were acquired using the 40X magnification. C) Representative images of invadopodia formation assays. Actin puncta was detected with phalloidin (red) and Alexa 488-labeled gelatin (green) was used as a specific substrate for the membrane-bound MMP-14 located at the edge of invadopodia. Arrows indicate areas of gelatin degradation. Images were acquired using a 100X magnification.
We observed that Src had an effect in the formation of thick stress fibers (Fig. 5A) , whereas FAK appeared to be not essential in this process (Fig. 5B ). However, both kinases appeared to be relevant for the leptin-induced morphological changes observed in MCF10A cells. Thus, we hypothesized that both kinases may be also be involved in invadopodia formation, as this structure contributes largely to the morphological and migratory phenotypes that emerge during EMT [77, 78] . Therefore, to determine the role of Src and FAK in the invadopodia formation in MCF10A cells stimulated with leptin, we performed similar gelatin degradation experiments in the presence and absence of the kinases' inhibitors. Our results show the actin puncta formation and an increase in the degradation of gelatin in leptin-treated cells, indicative of invadopodia formation (Fig. 6 ). When the cells were treated with either Src-, or the FAK-specific inhibitors, actin puncta formation and gelatin degradation was not observed (Fig. 6 ). Is noteworthy that MMP-14 is a predominant transmembrane protease activated in the regions where invadopodia is formed [79] ; thus we cannot overrule the possibility that both kinases also promotes the activation of MMP-14 in a leptin-dependent manner. Representative images of MCF10A cells pre-treated or not with PP2 or PF-573228 (10 µM) for 30 min and subsequently incubated in the presence or absence of leptin (400 ng/mL) for 24 h. Actin puncta was detected with phalloidin (red) and Alexa 488-labeled gelatin (green) was used as a specific substrate for the membrane-bound MMP-14 located at the edge of invadopodia. Arrows indicate areas of gelatin degradation. Images were acquired using a 100X magnification.
Leptin induces cell invasion in a Src-dependent pathway in MCF10A cells
At this point, we have evidence of the requirement of Src and FAK in the secretion and/or activation of at least three MMPs relevant for EMT. Previously, our group showed that FAK is necessary for the acquisition of enhanced migratory capabilities driven by leptin in MCF10A cells [43] . Therefore, here we evaluated the contribution of Src in cell invasion in MCF10A cells stimulated with leptin. Invasion assays were performed in transwell chambers [48] , with MCF10A cells that were treated or not with leptin and PP2. Figure 7 shows that control cells have reduced mobility, and are not capable to colonize the matrix in the transwell, while leptin-treated cells were capable to invade this area. As expected, Src appeared to be an essential kinase in this process, as the leptin-induced invasion properties of MCF10A cells treated with PP2 was ablated. These data suggest that Src is a relevant kinase for the establishment of the migratory and invasive phenotype during early stages of EMT. 
Discussion
EMT is a reversible cellular process by which epithelial cells undergo trans-differentiation events from an epithelial to a mesenchymal phenotype in where EMT-related transcription factors are key molecules [3] . EMT is also associated with tumor progression and the invasive and metastatic phenotype in cancer cells [14] . Here, we studied leptin, a hormone primarily secreted by adipocytes, which is also secreted, in lesser extent, in normal and tumorigenic mammary tissue [80, 81] . Several studies have established the association between overexpression of leptin and its receptor, ObR, during breast cancer progression [4] [5] [6] .
Expression and hyperactivation of various molecules (kinases, TFs, MMPs, adhesion proteins) are associated with the activation of the EMT program, a couple of examples are the kinases Src and FAK [82] . In this study, we evaluated the effect of leptin in the activation of these kinases in the regulation of EMT-related TFs and for invasion-related processes in the non-tumorigenic mammary epithelial cell line MCF10A. Src and FAK activation was evaluated through the phosphorylation levels at Y418 and Y397, respectively, in MCF10A cells stimulated with leptin 400 ng/mL. Our results showed early maximal activation peaks for both kinases within 10-15 min of leptin stimulation. These data is consistent with our previous report, where leptin induced the activation of FAK between 10-30 min of stimulation in MCF10A, MCF7 and MDA-MB-231 cells [43, 51] . However, the mechanism by which leptin activates Src and FAK in MCF10A remain unclear, and several alternatives should be explored in the future. For instance, in circulating angiogenic cells, leptin induces Src activation through the αvβ5 integrins pathway [83] . Likewise, in the colon adenocarcinoma SW480 cell line, FAK activation induced by leptin is also dependent on integrins activation [84] . In contrast, in MDA-MB-231 cells Src activation is SHP2dependent which binds to the phosphorylated Y985 of the ObR receptor [85] . Therefore, further studies should be directed to elucidate the mechanism of activation of both kinases in response to leptin in the MCF10A epithelial cell line.
The EMT program activation is regulated by specific TFs such as Twist and -catenin, which are associated with cell invasion and metastasis [13, 14] . In this study, we showed that leptininduced Twist expression is an early event that may contribute to the initial establishment of EMT, which is in agreement with studies performed in the breast cancer cell lines MCF7 and SK-BR-3, where leptin also induced the expression of this TF [9, 10] . Here, we demonstrated that Twist expression and localization is regulated in a Src-and FAK-dependent manner. These novel activation pathways for Twist contribute to our understanding of the signaling and transcriptional events associated to this factor during leptin-induced EMT. For instance, it is well known that in MDA-MB-231 cells, Src induces STAT3 activation, a TF that regulates the TWIST1 expression [58] . Leptin also activates STAT3 in a JAK2-dependent manner, and allows its dimerization and nuclear translocation where it regulates the expression of the TWIST1 gene [86, 87] . In PCa cells, which are from prostate origin, but derived from their metastatic site, the bone, the inhibition of FAK decreased the activation of the Hypoxia-inducible factor 1-α (HIF-1α), which also regulates TWIST1 [88] . Furthermore, β-catenin, whose primary function is to maintain adherent junctions by interacting with E-cadherin, α-catenin and the actin cytoskeleton regulating cell-cell contact.
-catenin can be relocated into the nucleus where acts as a transcription factor forming complexes with DNA binding proteins such as TCF/LEF [89, 90] . In this study, we observed that β-catenin expression increases in leptin-stimulated cells in addition to a nuclear relocation of β-catenin at 3 h. These findings might be related to the decrease in the expression or changes in the location of proteins at adherent junctions, particularly, Ecadherin and β-catenin plays an important role in the induction of EMT [91] . The overexpression of both TFs and their nuclear location could be related to the gene expression of the EMT markers, suggesting that leptin induces EMT-related processes such as MMPs expression and activation as well as invasion in mammary epithelial cells MCF10A.
Overexpression of Twist and β-catenin is associated with EMT and invasiveness [92] [93] [94] . Actin re-organization and the formation of stress fibers are essential events for cell migration, and are considered the hallmark of EMT [95, 96] . Studies have shown that leptin induces remodeling of the cytoskeleton and morphological changes in mammary epithelial cells [43, 71] , and in MDA-MB-231 breast cancer cells FAK and Src regulate the formation of stress fibers [97] . We demonstrated that leptin induces the formation of stress fibers in a Srcdependent manner, and that both kinases contributed to the morphological changes observed upon leptin treatment. One of the functional consequences of EMT is invasion, which initiates with invadopodia formation promoting the local degradation of ECM, through the recruitment of MMPs, such as MMP-2 and MMP-9, and MMP-14 [75, 98, 99] . In our study, we observed that leptin induces the expression, secretion and activation of these MMPs, and promotes the invadopodia formation in a Src-and FAK-dependent manner. In cellular models of breast cancer, both, MMP-2 and MMP-9, participate in invasion, metastasis and angiogenesis [32] . A study conducted in multiple tumor cell lines showed that the expression of MMP-9 is regulated by the FAK-ERK1/2-Akt pathway, through the regulation of p65 and c-Fos [100] . While in SW480 cells the expression of MMP-2 is dependent on the FAK/Src and ERK1/2 pathways [101] . Similarly, a study conducted in the A549 human non-small-cell lung carcinoma cell line, FAK-Src, ERK1/2 kinases, and β-catenin regulate the expression of MMP-2 and MMP-9 [102] .
Conclusions
Our results demonstrate that leptin induces the activation of Src and FAK, which in turn regulate the expression of the EMT-related TFs β-catenin and Twist. Morphological remodeling and invadopodia formation, as well as MMPs secretion and activation, appear to be also effectors of leptin-induced EMT. All together, these EMT markers play a key role during cell invasion of tumor cells ( Fig. 8 ). 
